Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients

Sei Naito, Naoki Yamamoto, Tatsuya Takayama, +18

European Urology

UrologyGenitourinary CancerMedicineRenal PathologyRenal Inflammation +5

Docetaxel Plus Prednisolone for the Treatment of Metastatic Hormone-refractory Prostate Cancer: A Multicenter Phase II Trial in Japan

Seiji Naito, Tadashi Tsukamoto, Hirofumi Koga, +4

Japanese Journal of Clinical Oncology

Ganglioside G(M3) overexpression induces apoptosis and reduces malignant potential in murine bladder cancer.

Ryuji Watanabe, Chikara Οhyama, Hiroshi Aoki, +7

PubMed

Chemoprevention StrategyApoptosisGlycobiologyCell DeathGanglioside G +19

Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan

Teppei Okamoto, Shingo Hatakeyama, Shintaro Narita, +15

World Journal of Urology

NutritionUrologyNutritional EpidemiologyMicronutrientsMedicine +5

Gamma‐knife radiosurgery for brain metastasis of renal cell carcinoma: Results in 42 patients

Senji Hoshi, Hidefumi Jokura, Hiroyuki Nakamura, +7

International Journal of Urology

Glycolipid composition in bladder tumor: A crucial role of GM3 ganglioside in tumor invasion

Sadafumi Kawamura, Chikara Οhyama, Ryuji Watanabe, +5

International Journal of Cancer

Diffraction and re-initiation of detonations behind a backward-facing step

Shigeharu OHYAGI, T. Obara, Senji Hoshi, +2

Shock Waves

EngineeringDetonation PhenomenonPhysicsWave PropagationDiffraction +3

Sialosyl‐Le^x expression defines invasive and metastatic properties of bladder carcinoma

Kenji Numahata, Makoto Satoh, Kazuko Handa, +7

Cancer

Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer

Shusuke Akamatsu, Masashi Kubota, Ryuji Uozumi, +22

European Urology Oncology

Novel Prognostic ModelSurgical OncologyUrologyGenitourinary CancerMedicine +5

Plasma chromogranin A in prostatic carcinoma and neuroendocrine tumors.

Noriko Kimura, Senji Hoshi, Masaru Takahashi, +3

PubMed